# US 2002/0119179 A1 · Implantable biodegradable devices for musculoskeletal repair or regeneration

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2002/0119179 A1
- Document ID: US20020119179A1
- Status: Published application
- Kind: A1
- Application number: 09/745,783
- Filed: 2000-12-22
- Published: 2002-08-29
- Earliest claimed: 2000-12-22
- Inventors: Alireza Rezania; Joseph John Hammer; Iksoo Chun; Mark Charles Zimmerman; Mora Carolynne Melican
- Web page: https://patentgrep.com/patent/US20020119179A1

## CPC

- A61L 27/58: Materials at least partially resorbable by the body
- A61L 27/48: with macromolecular fillers
- Y10T 442/2525: Coating or impregnation functions biologically [e.g., insect repellent, antiseptic, insecticide, bactericide, etc.]
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

An implantable biodegradable device is disclosed containing a fibrous matrix, the fibrous matrix being constructed from fibers A and fibers B, wherein fibers A biodegrade faster than fibers B, fibers A and fibers B are present in relative amounts and are organized such that the fibrous matrix is provided with properties useful in repair and/or regeneration of mammalian tissue.

## Claims

### Claim 1

An implantable, biodegradable device, comprising a fibrous matrix, said fibrous matrix comprising first fibers A and second fibers B, wherein fibers A biodegrade faster than fibers B, and wherein fibers A and B are present in relative amounts and are organized such that the fibrous matrix is provided with properties useful in repair and/or regeneration of mammalian tissue.

### Claim 2 (depends on 1)

The device of claim 1 wherein the rate of resorption of the fibrous matrix approximates the rate of replacement of the fibrous matrix by tissue.

### Claim 3 (depends on 1)

The device of claim 1 wherein the weight ratio of fibers A to fibers B is from about 19:1 to about 1:19.

### Claim 4 (depends on 1)

The device of claim 1 wherein the porosity of the fibrous matrix is effective to facilitate uniform tissue growth therein.

### Claim 5 (depends on 4)

The device of claim 4 wherein pores ranging in size from about 20 microns to about 400 microns are interconnected and comprise from about 70 percent to about 95 percent of the fibrous matrix.

### Claim 6 (depends on 1)

The device of claim 1 wherein fibers A and fibers B comprise a biodegradable polymer.

### Claim 7 (depends on 6)

The device of claim 6 wherein the biodegradable polymer is selected from the group consisting of aliphatic polyesters, poly(amino acids), copoly(ether-esters), polyalkylene oxalates, polyamides, poly(iminocarbonates), polyorthoesters, polyoxaesters, polyamidoesters, poly(anhydrides), polyphosphazenes and biopolymers.

### Claim 8 (depends on 6)

The device of claim 6 wherein the fibrous matrix comprises from about 50 to about 99 weight percent of fibers A prepared from a polyglycolic acid/polylactic acid (PGA/PLA) copolymer, and from about 50 to about 1 weight percent of fibers B prepared from a polylactic acid/polyglycolic acid (PLA/PGA) copolymer.

### Claim 9 (depends on 8)

The device of claim 8 wherein the PGA/PLA copolymer comprises about 90 percent PGA and about 10 percent PLA, and the PLA/PGA copolymer comprises about 95 percent PLA and about 5 percent PGA.

### Claim 10 (depends on 7)

The device of claim 7 wherein the polyoxaesters comprises amine groups.

### Claim 11 (depends on 1)

The device of claim 1 wherein the fibrous matrix comprises an organized network selected from the group consisting of threads, yarns, nets, laces, felts and nonwovens.

### Claim 12 (depends on 1)

The device of claim 1 wherein the fibrous matrix comprises a configuration selected from the group consisting of a disk, a rectangle, a square, a tube and a star.

### Claim 13 (depends on 1)

The device of claim 1 wherein the diameters of fibers A and fibers B range from about 5 microns to about 100 microns.

### Claim 14 (depends on 1)

The device of claim 1 wherein fibers A and fibers B are bonded together by a biodegradable polymeric binder.

### Claim 15 (depends on 14)

The device of claim 14 wherein the biodegradable polymeric binder is selected from the group consisting of polycaprolactone, polylactic acid, polydioxanone and polyglycolic acid.

### Claim 16 (depends on 1)

The device of claim 1 wherein the fibrous matrix comprises a gradient structure.

### Claim 17 (depends on 1)

The device of claim 1 wherein said fibrous matrix comprises a continuous transition from fibers A at the periphery of the device to fibers B at the center of the device.

### Claim 18 (depends on 1)

The device of claim 1 wherein said fibrous matrix comprises a continuous transition from fibers A at the top of the device to fibers B at the bottom of the device

### Claim 19 (depends on 1)

The device of claim 1 wherein the fibrous matrix further comprises a biodegradable, fibrous polymeric coating.

### Claim 20 (depends on 19)

The device of claim 19 wherein the biodegradable polymeric coating is selected from the group consisting of polylactic acid, polyglycolic acid, polycaprolactone and copolymers thereof.

### Claim 21 (depends on 1)

The device of claim 1 wherein the fibrous matrix is chemically crosslinked or combined with hydrogels.

### Claim 22 (depends on 1)

The device of claim 1 wherein the fibrous matrix is coated with an adhesive biological factor selected from the group consisting of fibronectin, vitronectin, “V-CAM, I-CAM, N-CAM, elastin, fibrillin, laminin, actin, myosin, collagen, microfilament, intermediate filament, antibody, and fragments thereof”
hyaluronic acids, glycosaminoglycans, collagens, peptide fragments, pleiotrophin, endothelin and tenascin-C.

### Claim 23 (depends on 1)

The device of claim 1 wherein the fibrous matrix is coated with a growth factor selected from the group consisting of members of TGF-β family, bone morphogenic proteins, fibroblast growth factors-1 and -2, platelet-derived growth factor-AA, and -BB, platelet rich plasma and vascular endothelial cell-derived growth factor (VECF).

### Claim 24 (depends on 1)

The device of claim 1 wherein the fibrous matrix further comprises seeded or cultured therein cells selected from the group consisting of bone marrow cells, stromal cells, stem cells, embryonic stem cells, chondrocytes, osteoblasts, osteocytes, fibroblasts, pluripotent cells, chondrocyte progenitors, osteoclasts, endothelial cells, macrophages, adipocytes, monocytes, plasma cells, mast cells, umbilical cord cells, leukocytes, epithelial cells, myoblasts, and precursor cells derived from adipose tissue.

### Claim 25 (depends on 1)

The device of claim 1 wherein said fibrous matrix comprises a first layer comprising a majority of filaments prepared from a 90/10 PGA/PLA copolymer and a second layer comprising a majority of filaments prepared from a 95/5 PLA/PGA copolymer.

### Claim 26 (depends on 1)

The device of claim 1 wherein fibers A and fibers B comprise a sheath/core construction, where each filament comprises a sheath of biodegradable polymer surrounding one or more cores comprising another biodegradable polymer.

### Claim 27 (depends on 1)

The implant of claim 1, further comprising a fabric barrier layer formed on at least one surface of the implant.

### Claim 28 (depends on 27)

The implant of claim 27, wherein the fabric barrier is formed on a top surface and a bottom surface of the implant.

### Claim 29 (depends on 27)

The implant of claim 27, wherein the fabric barrier is a dense, fibrous fabric that is effective as a barrier to hyperplasia and tissue adhesion.

### Claim 30 (depends on 29)

The implant of claim 29, wherein the fabric barrier is formed of an electrostatically spun aliphatic polyester.
